Innovative Care for Mental Health Patients
At Mystic Health, we collaborate with providers to tackle the complex challenges of treatment-resistant mental health conditions such as depression, anxiety, and PTSD.
Through ketamine-assisted psychotherapy (KAP), we offer an evidence-based approach that complements traditional psychiatric treatments, providing patients with a renewed sense of well-being and emotional resilience.
The Transformative Power of
Psychedelic-Assisted Therapy with Ketamine
Ketamine treatments are at the forefront of a renaissance in mental well-being, increasingly recognized for their profound ability to address a wide spectrum of emotional and psychological challenges.
This compassionate and holistic approach represents a significant leap forward, offering a new pathway to healing and renewed hope.
INSIGHTS & SERENITY
& PURPOSE
RELIEF & INNER CALM
INSIGHTS & SERENITY
Psychedelic-assisted treatments facilitate profound altered states of consciousness, guiding you to access and process deep-seated emotions and past experiences.
This transformative journey can lead to powerful psycho-spiritual insights, enabling a deep reconciliation with your unique journey, alleviating existential distress, and finding profound peace in your current life stage.
RELIEF & INNER CALM
Ketamine-assisted therapy offers remarkable relief from severe anxiety and deep-seated depression, often providing breakthroughs where traditional approaches have fallen short.
By gently resetting brain activity patterns, these therapies foster rapid and sustained
improvements in mood and outlook, empowering you to regain a deep sense of hope, comfort, and holistic well-being.
& PURPOSE
Psychedelic medicine offers a unique pathway for individuals navigating significant life challenges to uncover new meanings and profound insights about their experiences.
This deeply personal process fosters a renewed sense of purpose, a deeper connection to life, and enhanced emotional and spiritual healing, helping you live fully and authentically.
How Ketamine-Assisted Psychotherapy (KAP) Helps
KAP combines the biological benefits of ketamine with the power of guided therapeutic support, targeting root causes of emotional distress while fostering neuroplasticity and emotional breakthroughs. Specifically, KAP:
Reduces symptoms of depression, anxiety, and PTSD.
Enhances neuroplasticity, promoting lasting emotional resilience.
Helps patients process unresolved trauma and gain emotional clarity.
Unlike IV ketamine alone, KAP includes preparation, guided ketamine sessions, and follow-up integration therapy to maximize therapeutic outcomes. Patients often report rapid relief and breakthroughs that are facilitated through transformative experiences.
By partnering with Mystic Health, various providers can expand their patients’ treatment options, while ensuring continuity of care and alignment with their existing mental health plan.
Comprehensive Support for Your Patients
Mystic Health provides a collaborative approach to offering cutting-edge care for patients who have not found relief through traditional methods. Our approach includes:
Care
Centered Focus
We aim to complement your practice by addressing persistent mental health challenges with a unique and transformative approach.
Meet the Team
We are driven by a shared commitment to pioneering advanced therapies, supporting healing, and creating transformative experiences for our patients.
Mystic Health’s Founder Story
Dr. Farzin’s journey into palliative care began with a profound personal loss - he lost his mother before the age of three. This early experience of grief planted the seeds for a lifelong exploration of suffering, healing, and what it means to find peace at the end of life.
Mystic Health is a response to the void Dr. Farzin experienced in
his own life, now filled with intention, compassion, and innovation.
Director of Clinical Strategy
Dr. Nick Schiavoni, M.D. is a board-certified anesthesiologist and the Director of Clinical Strategy at Mystic Health. He completed his residency in anesthesiology and fellowship in acute pain management at the University of Colorado and now specializes in ketamine-assisted therapy with innovative approaches to psychedelic medicine. Dr. Schiavoni is dedicated to advancing evidence-based, whole-person care while shaping cutting-edge treatment protocols.
& Palliative Care Physician
Dr. Thais is an integrative medicine and palliative care internist committed to holistic healing. With training in Brazil and at UCLA, she blends internal medicine, acupuncture, mindfulness, and psychedelic care to promote balance and comfort. Dr. Salles Araujo focuses on traditional Chinese medicine, nature, and meaning-centered care to support patients and their loved ones through life’s most challenging experiences.
Lisa specializes in trauma, anxiety, stress, illness, grief, and caregiver support. Trained in Hakomi Somatic, attachment, and transpersonal psychotherapy, she is a death doula and mindfulness teacher for over 15 years. A graduate of Spirit Rock’s Advanced Practitioner’s Program, she teaches MBSR and Trauma-Sensitive Mindfulness. Lisa is certified in KAP through Polaris and CIIS’s Psychedelic Therapy Program.
Haleh specializes in trauma, mood disorders, eating disorders, substance abuse, and generational trauma. With over 20 years in private practice, she integrates collaborative research experience from UCLA and Planned Parenthood to provide compassionate care to individuals and families. Haleh is bilingual in Farsi and English, offering support to diverse communities.
Kabir brings seven years of experience in mental health operations and communications, specializing in building systems that elevate care. At My Ketamine Home (former COO) & Nue Life Health (former Chief of Staff), he worked with a team that supported 10,000 patients and facilitated 90,000+ treatments. Now at Mystic Health, Kabir collaborates with clinicians to redefine holistic mental health and palliative care through innovative, personalized treatments, fostering transformative healing for patients and families.
Stephanie Karzon Abrams is a neuropharmacologist, researcher, and clinical operations strategist. With experience in neurology, intensive care, and medical device at Johnson & Johnson, she is a recognized leader in integrative healthcare. Her work bridges neuroscience, women's health, plant medicine, and the healing power of music.
Gizem graduated from Brooklyn’s Pratt Institute with a Bachelor of Fine Arts in Interior Design. Her thesis project was dedicated to exploring how a physical space can help create mental agency. In light of that, she designed a non-denominational sanctuary for spiritual refuge which aims to educate people on the power of the mind and the impact it has on the quality of our lives. Gizem has worked closely with several prestigious New York based designers in the industry such as Carlos Mota, Muriel Brandolini, & Poonam Khanna (The Unionworks Architecture & Design). She has a passion for our cause and aspires to elevate our patients’ experience wherever possible.
Rick Doblin, PhD, is one of the most influential voices in the modern psychedelic movement. As the founder of the Multidisciplinary Association for Psychedelic Studies (MAPS), Rick has spent more than 35 years leading the global conversation around the responsible and ethical use of psychedelic medicines. His work has been instrumental in advancing clinical research, shaping public policy, and restoring scientific legitimacy to therapies that address trauma, depression, and end-of-life anxiety.
Rael Cahn, MD, PhD, is Clinical Associate Professor of Psychiatry with the USC Department of Psychiatry and Director of the USC Center for Mindfulness Science as well as the Mindfulness and Psychedelic Therapy lab at the USC Brain and Creativity Institute. He is currently running a Mindfulness-Assisted Psychedelic Therapy research project aimed at assessing the complementarity of meditative training and psychedelic therapy and their impact on the experience of self, measures of well-being and neurobiological change.
Dr. Amir Vokshoor is a board-certified neurosurgeon specializing in minimally invasive surgical treatments. With over 20 years of dedicated experience, he is a leading advocate for advancements in the field, recognized for his expertise in spinal disc replacement, motion-preserving technologies, and his pioneering integrative holistic approach to brain and spine health. Currently serving as the Chief of Surgery at Providence St. John’s Health Center, he has earned an international reputation for his surgical skills and commitment to a comprehensive perspective on brain and spine wellness.
Farhad Mohit is the founder of GoodParty.org, empowering independent candidates with free AI-powered tools. He also founded Gifted Savings, a non-profit focused on direct wealth gifting. Previously, he founded Flipagram (now TikTok), Shopzilla, and BizRate.com, pioneering advancements in e-commerce and short-form video. Farhad serves on the boards of Burning Man and Farhang Foundation and holds an MBA from Wharton and a B.S. from UCLA.
Dr. John Horton is an adult psychiatrist and palliative care physician at UCLA Health and Clinical Instructor at UCLA’s David Geffen School of Medicine. He supports patients and families at the UCLA Simms-Mann Center for Integrative Oncology and serves on the Inpatient Palliative Care Service. His work focuses on easing distress around life-threatening illnesses and advancing the thoughtful integration of psychedelics in palliative care.
As a passionate Care Advisor at Mystic Health, Emily Dorrien Flynn is instrumental in expanding the Patient Resource Center, enhancing care navigation, and strengthening patient support across every phase of the healing journey. She's driven by the philosophy that profound healing, transformation, and peace are always within reach.
Is Ketamine Therapy
Right for Your Patients?
Patients who may benefit from KAP include those experiencing:
FAQs
1. Am I eligible for ketamine therapy?
2. Does insurance cover the cost of ketamine therapy?
3. How many ketamine treatments will I need?
We recommend two initial treatments to determine suitability and adjust dosage. After these sessions, additional treatments are available based on your progress and specific requirements.